U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Health economic analysis of vaccine options for the polio eradication endgame: 2022–2036

Supporting Files
File Language:
English


Details

  • Alternative Title:
    Expert Rev Vaccines
  • Personal Author:
  • Description:
    Background:

    Multiple vaccine options are available for polio prevention and risk management. Integrated global risk, economic, and poliovirus transmission modeling provides a tool to explore the dynamics of ending all use of one or more poliovirus vaccines to simplify the polio eradication endgame.

    Research design and methods:

    With global reported cases of poliomyelitis trending higher since 2016, we apply an integrated global model to simulate prospective vaccine policies and strategies for OPV-using countries starting with initial conditions that correspond to the epidemiological poliovirus transmission situation at the beginning of 2022.

    Results:

    Abruptly ending all OPV use in 2023 and relying only on IPV to prevent paralysis with current routine immunization coverage would lead to expected reestablished endemic transmission of poliovirus types 1 and 2, and approximately 150,000 expected cases of poliomyelitis per year. Alternatively, if OPV-using countries restart trivalent OPV (tOPV) use for all immunization activities and end IPV use, the model shows the lowest anticipated annual polio cases and lowest costs.

    Conclusions:

    Poor global risk management and coordination of OPV cessation remain a critical failure mode for the polio endgame, and national and global decision makers face difficult choices due to multiple available polio vaccine options and immunization strategies.

  • Subjects:
  • Keywords:
  • Source:
    Expert Rev Vaccines. 21(11):1667-1674
  • Pubmed ID:
    36154436
  • Pubmed Central ID:
    PMC10116513
  • Document Type:
  • Funding:
  • Volume:
    21
  • Issue:
    11
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:b77b3bb252f98c51aa871993c6acf6c64ab74ead31c3f7a4096310c55b881eb2d979fa2b83b862e0d7eaa5bdfeae75a95389105c4da7a86a1589d2d7408da429
  • Download URL:
  • File Type:
    Filetype[PDF - 363.52 KB ]
File Language:
English
ON THIS PAGE
 Was this page helpful?
 Found an issue?
Send us an email at:
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.